Our firm

Symbiosis is committed to providing the highest quality service possible and to ensure this happens we employ attorneys with higher degrees and post-doctoral research experience across a broad range of technical disciplines in the bioscience sector. We believe this post-doctoral research experience enables us to fully understand the technology behind your ideas and maximise the protection we can acquire for you. We also undertake continuing professional development to keep up to date on issues that affect our clients.

Symbiosis understands that protection for IP can be expensive and so we have streamlined our business to maximise efficiency and the associated cost savings are passed onto our clients via our highly competitive charging rates. To help you plan ahead we can provide cost estimates for any stage of the patenting process with reasonable levels of reliability.

But, Symbiosis is about more than providing the best service at the best rate, we take care to ensure everyone in our firm is enjoyably engaged in their work.

Our expertise

Our senior staff have been working in the Life Sciences and Chemistry for many decades and so we have gained a wealth of experience and expert knowledge in many aspects of patent drafting, prosecution and enforcement in the UK, Europe and internationally.

During this time we have established relationships with associates around the world who share our business values and it is with these associates that we work to safeguard our clients’ overseas interests.

Our expertise also enables us to tailor our services to suit our clients needs with a view to fostering long term relationships that are founded on collaboration and loyalty.

Our skills include expertise in personalised medicine, drug delivery, therapeutics, regenerative medicine, vaccines, antibodies, gene therapy, diagnostic/prognostic tests, medical & veterinary devices, small molecule therapeutics, formulations, pharmaceutical compositions, recombinant animal and plant materials, biofuels and clean technologies.

"Our two companies collaborate very well together to optimise the commercial benefits of the Glycologic Limited portfolio of activities."

Richard Tester
Managing Director, Glycologic Limited

"Andrew gave us the confidence that the final terms agreed were fair and in line with the current best practice"

UK University Head of Tech Transfer

"Vast experience in commercialising science and technology"

Senior UK Patent Attorney

"Driven, dedicated and knowledgeable in the whole spectrum of work covering commercialisation of technology"

UK University Senior Tech Transfer

"Result oriented, very responsive, a value creator and a person with a clear vision and strategy"

Senior Corporate Counsel

"Excellent technical licensing and deal-making skills, [a] can-do attitude and an inherent sense of value to each assignment"

Senior Leader, Corporate

"The work carried out by Symbiosis has always been of high quality. The team have a wealth of experience and understanding in life sciences, which means they are able to provide advice on patent filing from the earliest stage right through prosecution."

IAM Patent 2022 Client Interview

"Their communications are clear and always in good time for action to be taken. They have established a good network of foreign associates and we have recently had successful filings in the USA, Japan and China without a need for extensive office action and its associated costs."

IAM Patent 2022 Client Interview

"Cardiff University has a longstanding relationship with Symbiosis IP and we have always experienced a consistently high quality range of IP services. We particularly appreciate the ability to provide bespoke advice for academic, TTO or industry audiences as appropriate and this has contributed significantly to our translational successes across the life sciences portfolio."

Rhodri Turner
Senior Technology Transfer Officer, Cardiff University

"Symbiosis maximises the value of IP generated by our inventors in a cost effective and efficient manner that meets our commercial objectives."

Martin Whitaker
CEO, Diurnal

"Lee Samuel readily understands technology and consistently demonstrates thorough knowledge of patent law, great attention to detail and efficient organisational skills, leading to successful grants."

IAM Patent 2022 Client Interview

"Andrew lived up to our expectations, helping us take a very hard negotiation over the line. We enjoyed working with him and would do so again. I would definitely recommend him to organisations trying to navigate IP licensing negotiations"


"It is not an exaggeration to state that our confidence in Rob and Symbiosis is such that the strategic direction of our company has been IP-led at all times."

IAM Patent 2022 Client Interview

"The service provided by Symbiosis is personal, efficient and highly professional."

IAM Patent 2022 Client Interview

"Mark Hoggins consistently delivers excellent service and detailed and informed responses to examiners, and helps clients understand each step and grow in their understanding of the IP protection process."

IAM Patent 2022 Client Interview

"Julie always asks the right questions and grasps the heart of the invention easily. Julie expresses herself very clearly and it is straightforward to communicate with her, in both written and oral form. She presents commercial strategies, thanks to her long experience in the field and concrete exposure to challenges that she has been able to overcome."

IAM Patent 2022 Client Interview

"One of those rare breeds who manage to combine considerable technical expertise with a keen business sense"

Senior Leader, Corporate

"It is a privilege to work with Symbiosis."

Prof. Richard Ross, CSO
Asterion Limited

"Symbiosis dives deep into the science and data and then gives an excellent assessment of the potential for the patent to be granted and the value of said patent."

IAM Patent 2022 Client Interview

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set analytics cookies that help us make improvements by measuring how you use the site. These will be set only if you accept.

For more detailed information about the cookies we use, see our Cookies page. Cookie Control Link Icon

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.